VTVT (STOCKS)
vTv Therapeutics Inc. Class A Common Stock
$30.850000
-0.930000 (-2.93%)
Prev close: $31.780000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Paul Jai Sekhri
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $122.93M
- Employees
- 23
- P/E (TTM)
- -29.16
- P/B (TTM)
- 1.59
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
3
Strong Buy
7
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Jun 2026 (Q2)
|
$-1.05 | $-1.01 | -0.0402 | -3.98% |
|
Mar 2026 (Q1)
|
$1.94 | $-0.10 | +2.0369 | +2,102.06% |
|
Dec 2025 (Q4)
|
$-0.58 | $-1.11 | +0.5298 | +47.74% |
|
Sep 2025 (Q3)
|
$-1.08 | $-1.00 | -0.0804 | -8.04% |
Financial Statements
| Revenues | $36.84M |
| Operating Expenses | $46.09M |
| Research and Development | $28.68M |
| Other Operating Expenses | $17.41M |
| Operating Income/Loss | -$9.25M |
| Income/Loss From Continuing Operations After Tax | -$6.40M |
| Income/Loss From Continuing Operations Before Tax | -$6.40M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$6.40M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$1.65M |
| Net Income/Loss Attributable To Parent | -$4.76M |
| Net Income/Loss Available To Common Stockholders, Basic | -$4.76M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Assets | $87.59M |
| Current Assets | $87.59M |
| Prepaid Expenses | $416.00K |
| Other Current Assets | $87.17M |
| Noncurrent Assets | $4.00K |
| Liabilities | $8.96M |
| Current Liabilities | $7.02M |
| Noncurrent Liabilities | $1.94M |
| Equity | $78.63M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $78.63M |
| Liabilities And Equity | $87.59M |
| Net Cash Flow From Operating Activities | -$16.76M |
| Net Cash Flow From Operating Activities, Continuing | -$16.76M |
| Net Cash Flow From Financing Activities | $77.48M |
| Net Cash Flow | -$2.29M |
| Net Cash Flow, Continuing | -$2.29M |
| Comprehensive Income/Loss | -$6.40M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$6.40M |
| Other Comprehensive Income/Loss | $0.00 |